![Gabriela Gruia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gabriela Gruia
Director/Board Member at
APREA THERAPEUTICS, INC.
Net worth: 784 $ as of 2026-09-29
Profile
Dr. Gabriela Gruia, MD, is an Independent Director at Aprea Therapeutics, Inc. and a Principal at Gabriela Gruia Consulting LLC.
She is on the Board of Directors at Aprea Therapeutics, Inc. and NETRIS Pharma SAS. Dr. Gruia was previously employed as an Independent Director by Molecular Templates, Inc., an Independent Director by TScan Therapeutics, Inc., an Independent Director by Tessa Therapeutics Ltd, a Chief Development Officer by Ichnos Sciences, Inc., and a SVP & Head-Global Regulatory Affairs by Novartis Oncology, Inc. She received her doctorate degree from Medicine & Pharmacy Carol Davila University of.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-15 | 1,045 ( 0.01% ) | 784 $ | 2026-09-29 | |
| 2026-05-19 | 0 ( -.--% ) | - $ | 2026-09-29 |
Gabriela Gruia active positions
| Companies | Position | Start |
|---|---|---|
| APREA THERAPEUTICS, INC. | Director/Board Member | 2023-05-04 |
Gabriela Gruia Consulting LLC | Founder | 2020-12-31 |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology Develops targeted therapies for the treatment of cancer | Director/Board Member | 2022-12-31 |
Former positions of Gabriela Gruia
| Companies | Position | End |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Director/Board Member | 2026-10-12 |
| MOLECULAR TEMPLATES, INC. | Chief Tech/Sci/R&D Officer | 2023-10-01 |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Corporate Officer/Principal | 2020-12-31 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 2020-01-31 |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Director/Board Member | - |
Education of Gabriela Gruia
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Health Technology |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology Develops targeted therapies for the treatment of cancer | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Medicine & Pharmacy Carol Davila University of
 Medicine & Pharmacy Carol Davila University of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Gabriela Gruia Consulting LLC |
- Stock Market
- Insiders
- Gabriela Gruia
